Brett Stevens

Professor Brett Michael Stevens is building collaborative efforts in the field of myelodysplastic syndrome research at the University of Colorado Anschutz Medical Campus. As an Associate Professor-Research in the SOM-MED Department, he is dedicated to advancing the understanding and treatment of this complex condition. His work primarily focuses on the metabolic targeting of heterogeneous myelodysplastic syndrome stem cells, a cutting-edge area of study that holds promise for improving patient outcomes. Professor Stevens is known for his collaborative spirit, working closely with researchers not only at the University of Colorado Anschutz Medical Campus but also across other CU campuses and beyond. His research is supported by funding from the National Institutes of Health (NIH), underscoring the significance and potential impact of his work in the medical community. Throughout his career, Professor Stevens has contributed extensively to the scientific literature, with multiple peer-reviewed manuscripts published in various esteemed journals. His publications reflect his commitment to advancing knowledge in the field and his ability to translate complex research findings into practical applications. In addition to his research endeavors, Professor Stevens is actively involved in mentoring the next generation of scientists. He provides guidance and support to students and junior researchers, fostering an environment of learning and innovation. His dedication to education and mentorship is a testament to his passion for nurturing future leaders in medical research. Professor Stevens's work is characterized by a deep commitment to improving the lives of patients with myelodysplastic syndrome. Through his research, collaborations, and mentorship, he continues to make significant contributions to the field, driving forward the understanding and treatment of this challenging condition.